Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Kidney International
|
April 4, 2008
The risk of acute renal failure in patients with chronic kidney disease
C Y Hsu, J D Ordoñez, G M Chertow, et al.
Cell
|
April 20, 1990
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure
J A Zack, S J Arrigo, S R Weitsman, et al.
Annals of Internal Medicine
|
September 19, 2001
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin
E M Hylek, S Regan, A S Go, et al.
JAMA
|
March 3, 1999
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction?
M G Shlipak, W L Lyons, A S Go, et al.
Annals of Internal Medicine
|
December 28, 1999
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study
A S Go, E M Hylek, L H Borowsky, et al.
Circulation
|
June 8, 2001
Glycemic control and heart failure among adult patients with diabetes
C Iribarren, A J Karter, A S Go, et al.
JAMA
|
May 10, 2001
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
A S Go, E M Hylek, K A Phillips, et al.
Journal of the American College of Cardiology
|
November 3, 2001
Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women
B G Angeja, M G Shlipak, A S Go, et al.
Circulation
|
July 6, 2000
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
A S Go, E M Hylek, K A Phillips, et al.
Journal of Virology
|
October 1, 1990
Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation
A J Cann, J A Zack, A S Go, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Kidney International
|
April 4, 2008
The risk of acute renal failure in patients with chronic kidney disease
C Y Hsu, J D Ordoñez, G M Chertow, et al.
Cell
|
April 20, 1990
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure
J A Zack, S J Arrigo, S R Weitsman, et al.
Annals of Internal Medicine
|
September 19, 2001
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin
E M Hylek, S Regan, A S Go, et al.
JAMA
|
March 3, 1999
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction?
M G Shlipak, W L Lyons, A S Go, et al.
Annals of Internal Medicine
|
December 28, 1999
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study
A S Go, E M Hylek, L H Borowsky, et al.
Circulation
|
June 8, 2001
Glycemic control and heart failure among adult patients with diabetes
C Iribarren, A J Karter, A S Go, et al.
JAMA
|
May 10, 2001
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
A S Go, E M Hylek, K A Phillips, et al.
Journal of the American College of Cardiology
|
November 3, 2001
Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women
B G Angeja, M G Shlipak, A S Go, et al.
Circulation
|
July 6, 2000
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
A S Go, E M Hylek, K A Phillips, et al.
Journal of Virology
|
October 1, 1990
Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation
A J Cann, J A Zack, A S Go, et al.
Page
of 3